|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1996-7-9
|
|
pubmed:abstractText |
To compare standard and intensive treatment strategies for patients with high-grade non-Hodgkin's lymphoma (NHL) of poor prognosis, defined by the international prognostic index.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
586-92
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8636775-Adolescent,
pubmed-meshheading:8636775-Adult,
pubmed-meshheading:8636775-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8636775-Bleomycin,
pubmed-meshheading:8636775-Busulfan,
pubmed-meshheading:8636775-Combined Modality Therapy,
pubmed-meshheading:8636775-Cyclophosphamide,
pubmed-meshheading:8636775-Cytarabine,
pubmed-meshheading:8636775-Etoposide,
pubmed-meshheading:8636775-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:8636775-Hodgkin Disease,
pubmed-meshheading:8636775-Humans,
pubmed-meshheading:8636775-Ifosfamide,
pubmed-meshheading:8636775-Methotrexate,
pubmed-meshheading:8636775-Middle Aged,
pubmed-meshheading:8636775-Prednisolone,
pubmed-meshheading:8636775-Prognosis,
pubmed-meshheading:8636775-Survival Rate,
pubmed-meshheading:8636775-Transplantation, Autologous,
pubmed-meshheading:8636775-Vincristine
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma.
|
|
pubmed:affiliation |
Department of Medical Oncology, Christie Hospital, Manchester, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
